Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 4 | Issue 3 | pp. 109–111Open access
Pharmacoeconomics guidelines: The need of hour for India
- 1*,
- 2
- 1 Departments of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, INDIA.
- 2 Oberoi Dental Clinic and Orthodontic Centre, Tagore Garden, New Delhi, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Sukhvinder Singh Oberoi
Departments of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, INDIA.
Email: drsukhvinder@gmail.com
- DOI:
- 10.4103/2230-973X.138338
How to cite
Oberoi, S. S., & Oberoi, A. Pharmacoeconomics guidelines: The need of hour for India. International Journal of Pharmaceutical Investigation, 4(3), 109–111. https://doi.org/10.4103/2230-973X.138338
Abstract
Although the government pays for approximately 20% of drugs used in India, private out-of-pocket expenditure in India on health-care is one of the highest in the world. Preparing pharmacoeconomics guidelines will be an important step in order to establish Health Technology Assessment (HTA) in India. Areas in which HTA could be applied in the Indian context include, drug pricing, development of clinical practice guidelines and prioritizing interventions that represent the greatest value within a limited budget. All this calls for action, both by government and civil-society organizations, to make access to essential medicines a priority.
Keywords
Subject
Article metadata
| Title | Pharmacoeconomics guidelines: The need of hour for India |
|---|---|
| Authors | Sukhvinder Singh Oberoi; Avneet Oberoi |
| Affiliations | Departments of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, INDIA.; Oberoi Dental Clinic and Orthodontic Centre, Tagore Garden, New Delhi, INDIA. |
| Corresponding author | drsukhvinder@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 4, Issue 3 |
Also in this issue
- Lipid nanoceuticals: Current status and future perspectivepp. 107–108
- Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucomapp. 112–118
- Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokineticspp. 119–130
- Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailabilitypp. 131–137
- Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: A randomized clinical trialpp. 138–141